FMP
Cidara Therapeutics, Inc.
CDTX
NASDAQ
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
12.63 USD
-0.37 (-2.93%)
About
ceo
Dr. Jeffrey L. Stein Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.cidara.com
exchange
NASDAQ
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-Co...
CIK
0001610618
ISIN
US1717571079
CUSIP
171757107
Address
6310 Nancy Ridge Drive
Phone
858 752 6170
Country
US
Employee
69
IPO Date
Apr 15, 2015
Summary
CIK
0001610618
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
171757107
ISIN
US1717571079
Country
US
Price
12.63
Beta
1.01
Volume Avg.
58.34k
Market Cap
57.61M
Shares
-
52-Week
10.0-29.6
DCF
2.26
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.43
P/B
-
Website
https://www.cidara.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CDTX News
It looks like there's no news available.
